These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2474527)
1. The role of glycocalyx in surface phagocytosis of Bacteroides spp., in the presence and absence of clindamycin. Veringa EM; Ferguson DA; Lambe DW; Verhoef J J Antimicrob Chemother; 1989 May; 23(5):711-20. PubMed ID: 2474527 [TBL] [Abstract][Full Text] [Related]
2. Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx. Veringa EM; Ferguson DA; Lambe DW; Verhoef J Zentralbl Bakteriol; 1989 Sep; 271(3):311-20. PubMed ID: 2529862 [TBL] [Abstract][Full Text] [Related]
3. Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes. Ferguson DA; Veringa EM; Mayberry WR; Overbeek BP; Lambe DW; Verhoef J Microbios; 1992; 69(278):53-65. PubMed ID: 1588843 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations. Veringa EM; Lambe DW; Ferguson DA; Verhoef J J Antimicrob Chemother; 1989 Apr; 23(4):577-87. PubMed ID: 2745261 [TBL] [Abstract][Full Text] [Related]
5. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus. Veringa EM; Verhoef J Chemotherapy; 1987; 33(4):243-9. PubMed ID: 3608624 [TBL] [Abstract][Full Text] [Related]
6. Clindamycin and its action on the susceptibility of pathogenic bacteria to phagocytosis. Gemmell CG Scand J Infect Dis Suppl; 1984; 43():17-23. PubMed ID: 6398907 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of phagocytosis of Bacteroides fragilis following incubation with clindamycin. Howard RJ; Soucy DM J Antimicrob Chemother; 1983 Oct; 12 Suppl C():63-8. PubMed ID: 6643342 [TBL] [Abstract][Full Text] [Related]
8. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli. Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702 [TBL] [Abstract][Full Text] [Related]
9. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria. Wade BH; Kasper DL; Mandell GL J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341 [TBL] [Abstract][Full Text] [Related]
10. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes. Bjornson AB; Bjornson HS; Kitko BP Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes. Gemmell CG; Peterson PK; Schmeling D; Mathews J; Quie PG Eur J Clin Microbiol; 1983 Aug; 2(4):327-34. PubMed ID: 6628373 [TBL] [Abstract][Full Text] [Related]
13. Effects of Bacteroides asaccharolyticus cells and B. fragilis surface components on serum opsonisation and phagocytosis. Jones GR; Gemmell CG J Med Microbiol; 1986 Nov; 22(3):225-9. PubMed ID: 3534273 [TBL] [Abstract][Full Text] [Related]
14. Influence of subinhibitory concentrations of clindamycin on opsonophagocytosis of Staphylococcus aureus, a protein-A-dependent process. Veringa EM; Verhoef J Antimicrob Agents Chemother; 1986 Nov; 30(5):796-7. PubMed ID: 3800357 [TBL] [Abstract][Full Text] [Related]
15. The Bacteroides glycocalyx as visualized by differential interference contrast microscopy. Lambe DW; Ferguson KP; Ferguson DA Can J Microbiol; 1988 Nov; 34(11):1189-95. PubMed ID: 3061617 [TBL] [Abstract][Full Text] [Related]
16. In-vivo effects of clindamycin on neutrophil function. Faden H; Hong JJ; Ogra PL J Antimicrob Chemother; 1985 Nov; 16(5):649-57. PubMed ID: 4077773 [TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis]. Bassler M; Just HM; Richter A; Zeller H; Daschner F Infection; 1984; 12(4):280-5. PubMed ID: 6490174 [TBL] [Abstract][Full Text] [Related]
18. Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes. Gemmell CG; O'Dowd A J Antimicrob Chemother; 1983 Dec; 12(6):587-97. PubMed ID: 6662837 [TBL] [Abstract][Full Text] [Related]
19. In-vivo effects of clindamycin on polymorphonuclear leucocyte phagocytosis and killing of gram-negative organisms. Bassaris HP; Lianou PE; Skoutelis AT; Papavassiliou JT J Antimicrob Chemother; 1987 Apr; 19(4):467-73. PubMed ID: 3583968 [TBL] [Abstract][Full Text] [Related]
20. Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages. de Fijter CW; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Donker AJ; Verhoef J J Antimicrob Chemother; 1990 Oct; 26(4):525-32. PubMed ID: 2254222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]